Esbriet
Esbriet is a covid 19 medication containing Pirfenidone, available as 200/400mg tablets.
- Category
- Covid 19 · Asthma Respiratory
- Active ingredient
- Pirfenidone
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 200/400mg
You will receive a quality generic equivalent, depending on stock.
Prescription rules on Esbriet vary by country.
Details
- Conditions
- Idiopathic pulmonary fibrosis
- Therapeutic Class
- Antifibrotic agent
- Pharmacological Class
- Pyridine carboxylic acid derivative
- Minor Side Effects
- nausea, rash, fatigue, diarrhoea, dyspepsia, abdominal pain
- Moderate Side Effects
- photosensitivity reaction, pruritus, dizziness, headache, decreased appetite
- Dosage Forms
- Film-coated tablet
- Administration Route
- Oral use
- Prescription Status
- Prescription medicine
- Originator
- Roche
- Onset Time
- 2–4 weeks
- Duration
- long-term
- Storage Instructions
- Store below 25°C, away from moisture and direct heat.
- Drug Interactions
- fluvoxamine, ciprofloxacin, tobacco
- Age Restrictions
- Not recommended for use in children or adolescents.
What you will receive
Esbriet is the originator brand name, made by Roche. We use it here to identify the medicine only; we are not affiliated with Roche and do not ship the original Esbriet.
- You receive a generic equivalent: the same active ingredient (Pirfenidone) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- A regulated generic matches the original ingredient for ingredient by legal standard.